.svg){kind=small}
.avif)
Solt DB uses the same illustration tools as scientists publishing in the world's top journals -- a first in finance.
The combination of simple language and clear visuals allows investors of all backgrounds to more deeply understand the biotech stocks they own, while scientists can gain a better grasp of the business of biotech.
Biotech stocks represent one of the few asset groups where the little guy authentically has an edge over Wall Street. You don't need penny stocks or ultra high-risk investments either.
Solt DB shares research, modeling, and portfolio frameworks backed by domain competence and a transparent, real-money track record.
-cropped.svg)
.svg){kind=small}
.svg)